Hangzhou Kang Ming Information Technology Co., Ltd, trading as “ClouDr” (HKG: 9955), has entered into a partnership with fellow Chinese company Yangtze River Pharmaceutical (Group) Co., Ltd. The collaboration will concentrate on providing digitalized marketing services within specific chronic disease sectors, with both parties looking to expand and deepen their business operations in chronic disease management. The goal is to establish a long-term partnership in the domestic digital pharmaceutical marketing space in China. Financial specifics of the agreement were not disclosed.- Flcube.com
Healthcare Big Data HKG: 9955 Kang Ming Information Technology Mobile health / APP Yangtze River Pharmaceutical
Recent news:
-
Three Senior Executives of Henan Topfond Pharmaceutical Under Investigation -
Leman Biotech Enters Zhongshan Life Science Park to Accelerate CAR-T Innovation -
BRL Medicine Inc. Secures Nearly $30 Million in B+ Round Financing to Advance Pipeline -
Chinese Biopharma Bio-Bank Corp. Aims for HKEX IPO, Focused on PDGF Therapies -
HutchMed Anticipates Milestone Payment as Takeda Launches Fruzaqla in Japan for CRC
